Growth Metrics

Bio-Techne (TECH) Non-Current Deferred Tax Liability (2016 - 2025)

Bio-Techne has reported Non-Current Deferred Tax Liability over the past 15 years, most recently at $11.0 million for Q4 2025.

  • Quarterly results put Non-Current Deferred Tax Liability at $11.0 million for Q4 2025, down 70.78% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (down 70.78% YoY), and the annual figure for FY2025 was $6.2 million, down 88.96%.
  • Non-Current Deferred Tax Liability for Q4 2025 was $11.0 million at Bio-Techne, down from $11.3 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for TECH hit a ceiling of $112.9 million in Q3 2022 and a floor of $4.1 million in Q3 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $80.3 million (2023), compared with a mean of $67.1 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 96.37% in 2023 and later skyrocketed 1119.93% in 2024.
  • Bio-Techne's Non-Current Deferred Tax Liability stood at $101.4 million in 2021, then grew by 9.82% to $111.4 million in 2022, then plummeted by 35.74% to $71.6 million in 2023, then plummeted by 47.3% to $37.7 million in 2024, then plummeted by 70.78% to $11.0 million in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $11.0 million (Q4 2025), $11.3 million (Q3 2025), and $6.2 million (Q2 2025) per Business Quant data.